# A Pharmacokinetic and Clotting Activity Study of FVIII-PEGLip

> **NCT04592692** · PHASE2 · UNKNOWN · sponsor: **Ascension Healthcare Development Limited** · enrollment: 20 (estimated)

## Conditions studied

- Hemophilia A With Inhibitor

## Interventions

- **DRUG:** PEGylated Liposome (PEGLip)

## Key facts

- **NCT ID:** NCT04592692
- **Lead sponsor:** Ascension Healthcare Development Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-12-23
- **Primary completion:** 2022-02-28
- **Final completion:** 2022-05-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2021-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04592692

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04592692, "A Pharmacokinetic and Clotting Activity Study of FVIII-PEGLip". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04592692. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*